Vedamurthy, M. and Humbert, P. 2018. A randomized, open label, comparative, five-arm, controlled study evaluating the benefit and tolerability of oral superoxide dismutase combined with gliadin as add-on neutraceutical therapy with standard therapy in Indian patients with melasma. International Journal of Research in Dermatology. 4, 4 (Oct. 2018), 471–478. DOI:https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20184453.